TapewireFind a company

person · Reporting owner

Avista Capital Partners IV GP, L.P.

Disclosed activity across 1 company

Tapewire entity
139316
SEC CIK
0001761195

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Organogenesis Holdings Inc.ORGO · Entity 6275Director · 10% ownerMay 14, 2021May 18, 2021

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A common stockSEC Table I · non-derivativeIndirectSee Notes7,721,298 Reported balance After 2021-05-14 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2021-05-14 · Other · Disposed 21,154,526 · Balance 7,721,298

F2: Represents an aggregate of 9,664,970 shares of common stock distributed by ACP Onshore and 11,489,556 shares of common stock distributed by ACP Offshore, in each case, on a pro rata basis to their respective limited partners in accordance with their organizational documents for no additional consideration (the "Distribution").

F3: Represents an aggregate of 4,811,747 shares of common stock directly held by ACP Onshore and 2,909,551 shares of common stock directly held by ACP Offshore, in each case following the Distribution.

F1: This statement is being filed by the following Reporting Persons: Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.

F6: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.

F7: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Class A common stockSEC Table I · non-derivativeIndirectSee notes95,384 Reported balance Holding disclosure · report date 2021-05-14 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 95,384

F4: Represents shares indirectly beneficially owned by Thompson Dean as trustee of a grantor retained annuity trust following the Distribution.

F6: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.

F7: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Class A common stockSEC Table I · non-derivativeIndirectSee notes71,538 Reported balance Holding disclosure · report date 2021-05-14 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 71,538

F5: Represents shares indirectly beneficially owned by David Burgstahler as trustee of a grantor retained annuity trust following the Distribution.

F6: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.

F7: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Filing footnotes · ownership attribution and instrument terms

F1: This statement is being filed by the following Reporting Persons: Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.

F2: Represents an aggregate of 9,664,970 shares of common stock distributed by ACP Onshore and 11,489,556 shares of common stock distributed by ACP Offshore, in each case, on a pro rata basis to their respective limited partners in accordance with their organizational documents for no additional consideration (the "Distribution").

F3: Represents an aggregate of 4,811,747 shares of common stock directly held by ACP Onshore and 2,909,551 shares of common stock directly held by ACP Offshore, in each case following the Distribution.

F4: Represents shares indirectly beneficially owned by Thompson Dean as trustee of a grantor retained annuity trust following the Distribution.

F5: Represents shares indirectly beneficially owned by David Burgstahler as trustee of a grantor retained annuity trust following the Distribution.

F6: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.

F7: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 14, 2021 Filed May 18, 2021 21:45 UTC Organogenesis Holdings Inc. ORGO · Entity 6275 OtherClass A common stock 21,154,526 $0.00 $0.00
Disclosure

SEC source: 0001140361-21-017951 · form4.xml · nonDerivative · entry 1

Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner

Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner

Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner

Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner

Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner

Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner

Dean Thompson · CIK 0001069096 · Director · 10% owner

Burgstahler David F · CIK 0001374179 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Notes

Disclosed balance after: 7,721,298

F2 · shares: Represents an aggregate of 9,664,970 shares of common stock distributed by ACP Onshore and 11,489,556 shares of common stock distributed by ACP Offshore, in each case, on a pro rata basis to their respective limited partners in accordance with their organizational documents for no additional consideration (the "Distribution").

F3 · shares: Represents an aggregate of 4,811,747 shares of common stock directly held by ACP Onshore and 2,909,551 shares of common stock directly held by ACP Offshore, in each case following the Distribution.

F2 · price: Represents an aggregate of 9,664,970 shares of common stock distributed by ACP Onshore and 11,489,556 shares of common stock distributed by ACP Offshore, in each case, on a pro rata basis to their respective limited partners in accordance with their organizational documents for no additional consideration (the "Distribution").

F3 · balance_after: Represents an aggregate of 4,811,747 shares of common stock directly held by ACP Onshore and 2,909,551 shares of common stock directly held by ACP Offshore, in each case following the Distribution.

F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.

F6 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.

F7 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
November 24, 2020 Filed Nov 24, 2020 18:10 UTC Organogenesis Holdings Inc. ORGO · Entity 6275 PurchaseClass A common stock 100 $5.00 $500.00
Disclosure

SEC source: 0001140361-20-026482 · form4.xml · nonDerivative · entry 2

Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner

Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner

Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner

Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner

Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner

Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner

Dean Thompson · CIK 0001069096 · Director · 10% owner

Burgstahler David F · CIK 0001374179 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Notes

Disclosed balance after: 29,924,515

F5 · shares: Represents an aggregate of 50 shares of Common Stock purchased by ACP Onshore and 50 shares of Common Stock purchased by ACP Offshore.

F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.

F6 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.

F7 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests

Read SEC document
November 20, 2020 Filed Nov 24, 2020 18:10 UTC Organogenesis Holdings Inc. ORGO · Entity 6275 PurchaseClass A common stock 2,739 $4.99 $13,670.62
Disclosure

SEC source: 0001140361-20-026482 · form4.xml · nonDerivative · entry 1

Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner

Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner

Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner

Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner

Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner

Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner

Dean Thompson · CIK 0001069096 · Director · 10% owner

Burgstahler David F · CIK 0001374179 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Notes

Disclosed balance after: 29,924,415

F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the Securities and Exchange Commission, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F3 · shares: Represents an aggregate of 1,373 shares of Common Stock purchased by ACP Onshore and 1,366 shares of Common Stock purchased by ACP Offshore.

F4 · price: Purchase prices range from $4.98 to $5.00 per share, inclusive.

F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.

F6 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.

F7 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests

Read SEC document
November 19, 2020 Filed Nov 19, 2020 19:14 UTC Organogenesis Holdings Inc. ORGO · Entity 6275 PurchaseClass A common stock 36,127 $4.97 $179,612.61
Disclosure

SEC source: 0001140361-20-026147 · form4.xml · nonDerivative · entry 4

Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner

Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner

Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner

Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner

Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner

Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner

Dean Thompson · CIK 0001069096 · Director · 10% owner

Burgstahler David F · CIK 0001374179 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Notes

Disclosed balance after: 29,921,676

F4 · shares: The number of securities reported represents an aggregate number of shares of Common Stock purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the Securities and Exchange Commission, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F9 · shares: Represents an aggregate of 18,111 shares of Common Stock purchased by ACP Onshore and 18,016 shares of Common Stock purchased by ACP Offshore.

F10 · price: Purchase prices range from $4.86 to $5.00 per share, inclusive.

F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.

F11 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.

F12 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
November 18, 2020 Filed Nov 19, 2020 19:14 UTC Organogenesis Holdings Inc. ORGO · Entity 6275 PurchaseClass A common stock 45,378 $4.68 $212,518.79
Disclosure

SEC source: 0001140361-20-026147 · form4.xml · nonDerivative · entry 3

Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner

Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner

Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner

Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner

Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner

Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner

Dean Thompson · CIK 0001069096 · Director · 10% owner

Burgstahler David F · CIK 0001374179 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Notes

Disclosed balance after: 29,885,549

F4 · shares: The number of securities reported represents an aggregate number of shares of Common Stock purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the Securities and Exchange Commission, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F7 · shares: Represents an aggregate of 22,747 shares of Common Stock purchased by ACP Onshore and 22,631 shares of Common Stock purchased by ACP Offshore.

F8 · price: Purchase prices range from $4.58 to $4.75 per share, inclusive.

F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.

F11 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.

F12 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
November 17, 2020 Filed Nov 19, 2020 19:14 UTC Organogenesis Holdings Inc. ORGO · Entity 6275 PurchaseClass A common stock 50,000 $4.45 $222,405.00
Disclosure

SEC source: 0001140361-20-026147 · form4.xml · nonDerivative · entry 2

Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner

Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner

Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner

Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner

Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner

Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner

Dean Thompson · CIK 0001069096 · Director · 10% owner

Burgstahler David F · CIK 0001374179 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Notes

Disclosed balance after: 29,840,171

F4 · shares: The number of securities reported represents an aggregate number of shares of Common Stock purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the Securities and Exchange Commission, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F5 · shares: Represents an aggregate of 25,065 shares of Common Stock purchased by ACP Onshore and 24,935 shares of Common Stock purchased by ACP Offshore.

F6 · price: Purchase prices range from $4.38 to $4.50 per share, inclusive.

F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.

F11 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.

F12 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
November 17, 2020 Filed Nov 19, 2020 19:14 UTC Organogenesis Holdings Inc. ORGO · Entity 6275 PurchaseClass A common stock 4,272,657 $3.25 $13,886,135.25
Disclosure

SEC source: 0001140361-20-026147 · form4.xml · nonDerivative · entry 1

Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner

Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner

Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner

Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner

Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner

Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner

Dean Thompson · CIK 0001069096 · Director · 10% owner

Burgstahler David F · CIK 0001374179 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Notes

Disclosed balance after: 29,790,171

F2 · shares: Represents an aggregate of 2,142,071 shares of Class A common stock of the Issuer ("Common Stock") purchased by ACP Onshore and 2,130,586 shares of Common Stock purchased by ACP Offshore in the Issuer's underwritten public offering (the "Offering") that was completed on November 17, 2020.

F3 · price: Represents the public offering price of $3.25 per share of Common Stock, without giving effect to the fee paid by the Issuer to Avista Capital Holdings, L.P., an affiliate of the Avista Funds ("Avista Management"), pursuant to the Fee Letter Agreement, dated November 12, 2020, among the Issuer, Avista Management and the Avista Funds, made in connection with the Offering, as described in the Issuer's Current Report on Form 8-K filed on November 18, 2020 and filed as Exhibit 10.1 thereto.

F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.

F11 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.

F12 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
March 16, 2020 Filed Mar 16, 2020 21:47 UTC Organogenesis Holdings Inc. ORGO · Entity 6275 PurchaseClass A common stock 75,000 $3.98 $298,132.50
Disclosure

SEC source: 0001140361-20-005973 · form4.xml · nonDerivative · entry 4

Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner

Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner

Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner

Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner

Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner

Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner

Dean Thompson · CIK 0001069096 · Director · 10% owner

Burgstahler David F · CIK 0001374179 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Notes

Disclosed balance after: 25,517,514

F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F12 · shares: Represents an aggregate of 37,601 shares of Common Stock purchased by ACP Onshore and 37,399 shares of Common Stock purchased by ACP Offshore.

F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F13 · price: Purchase prices range from $3.67 to $4.29 per share, inclusive.

F14 · balance_after: Represents 12,267,300 shares of Common Stock owned directly by ACP Onshore, 12,201,523 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor.

F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.

F15 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.

F16 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
March 13, 2020 Filed Mar 16, 2020 21:47 UTC Organogenesis Holdings Inc. ORGO · Entity 6275 PurchaseClass A common stock 135,000 $4.31 $581,283.00
Disclosure

SEC source: 0001140361-20-005973 · form4.xml · nonDerivative · entry 3

Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner

Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner

Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner

Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner

Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner

Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner

Dean Thompson · CIK 0001069096 · Director · 10% owner

Burgstahler David F · CIK 0001374179 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Notes

Disclosed balance after: 25,442,514

F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F9 · shares: Represents an aggregate of 67,681 shares of Common Stock purchased by ACP Onshore and 67,319 shares of Common Stock purchased by ACP Offshore.

F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F10 · price: Purchase prices range from $4.02 to $4.47 per share, inclusive.

F11 · balance_after: Represents 12,229,699 shares of Common Stock owned directly by ACP Onshore, 12,164,124 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor.

F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.

F15 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.

F16 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
March 12, 2020 Filed Mar 16, 2020 21:47 UTC Organogenesis Holdings Inc. ORGO · Entity 6275 PurchaseClass A common stock 141,462 $4.17 $590,377.51
Disclosure

SEC source: 0001140361-20-005973 · form4.xml · nonDerivative · entry 2

Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner

Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner

Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner

Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner

Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner

Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner

Dean Thompson · CIK 0001069096 · Director · 10% owner

Burgstahler David F · CIK 0001374179 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Notes

Disclosed balance after: 25,307,514

F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F6 · shares: Represents an aggregate of 70,921 shares of Common Stock purchased by ACP Onshore and 70,541 shares of Common Stock purchased by ACP Offshore.

F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F7 · price: Purchase prices range from $3.975 to $4.50 per share, inclusive.

F8 · balance_after: Represents 12,162,018 shares of Common Stock owned directly by ACP Onshore, 12,096,805 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor.

F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.

F15 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.

F16 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
March 12, 2020 Filed Mar 16, 2020 21:47 UTC Organogenesis Holdings Inc. ORGO · Entity 6275 PurchaseClass A common stock 190,887 $3.62 $691,163.65
Disclosure

SEC source: 0001140361-20-005973 · form4.xml · nonDerivative · entry 1

Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner

Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner

Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner

Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner

Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner

Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner

Dean Thompson · CIK 0001069096 · Director · 10% owner

Burgstahler David F · CIK 0001374179 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Notes

Disclosed balance after: 25,166,052

F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F3 · shares: Represents an aggregate of 95,700 shares of Common Stock purchased by ACP Onshore and 95,187 shares of Common Stock purchased by ACP Offshore.

F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F4 · price: Purchase prices range from $2.98 to $3.97 per share, inclusive.

F5 · balance_after: Represents 12,091,097 shares of Common Stock owned directly by ACP Onshore, 12,026,264 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor.

F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.

F15 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.

F16 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
November 26, 2019 Filed Nov 27, 2019 16:17 UTC Organogenesis Holdings Inc. ORGO · Entity 6275 PurchaseClass A common stock 6,000,000 $5.00 $30,000,000.00
Disclosure

SEC source: 0001140361-19-021634 · form4.xml · nonDerivative · entry 1

Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner

Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner

Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner

Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner

Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner

Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner

Dean Thompson · CIK 0001069096 · Director · 10% owner

Burgstahler David F · CIK 0001374179 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Notes

Disclosed balance after: 24,975,165

F2 · shares: Represents an aggregate of 3,008,064 shares of Common Stock purchased by ACP Onshore and 2,991,936 shares of Common Stock purchased by ACP Offshore in the Issuer's underwritten public offering (the "Offering") that was completed on November 26, 2019.

F3 · price: Represents the public offering price of $5.00 per share of Common Stock, without giving effect to the fee paid by the Issuer to Avista Capital Holdings, L.P., an affiliate of the Avista Funds ("Avista Management"), pursuant to the Fee Letter Agreement, dated November 19, 2019, among the Issuer, Avista Management and the Avista Funds, made in connection with the Offering, as described in the Issuer's Current Report on Form 8-K filed on November 22, 2019 and filed as Exhibit 10.1 thereto.

F2 · balance_after: Represents an aggregate of 3,008,064 shares of Common Stock purchased by ACP Onshore and 2,991,936 shares of Common Stock purchased by ACP Offshore in the Issuer's underwritten public offering (the "Offering") that was completed on November 26, 2019.

F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore" and together with ACP Onshore, the "Avista Funds"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
September 12, 2019 Filed Sep 13, 2019 18:47 UTC Organogenesis Holdings Inc. ORGO · Entity 6275 PurchaseClass A common stock 413,900 $6.25 $2,585,343.57
Disclosure

SEC source: 0001140361-19-016669 · form4.xml · nonDerivative · entry 2

Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner

Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner

Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner

Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner

Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner

Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner

Dean Thompson · CIK 0001069096 · Director · 10% owner

Burgstahler David F · CIK 0001374179 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Notes

Disclosed balance after: 18,975,165

F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F6 · shares: Represents an aggregate of 207,507 shares of Common Stock purchased by ACP Onshore and 206,393 shares of Common Stock purchased by ACP Offshore.

F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F7 · price: Purchase prices range from $5.62 to $6.25 per share, inclusive.

F8 · balance_after: Represents 8,987,333 shares of Common Stock owned directly by ACP Onshore, 8,939,141 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor.

F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.

F9 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.

F10 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
September 11, 2019 Filed Sep 13, 2019 18:47 UTC Organogenesis Holdings Inc. ORGO · Entity 6275 PurchaseClass A common stock 447,000 $5.75 $2,570,428.80
Disclosure

SEC source: 0001140361-19-016669 · form4.xml · nonDerivative · entry 1

Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner

Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner

Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner

Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner

Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner

Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner

Dean Thompson · CIK 0001069096 · Director · 10% owner

Burgstahler David F · CIK 0001374179 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Notes

Disclosed balance after: 18,561,265

F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F3 · shares: Represents an aggregate of 224,101 shares of Common Stock purchased by ACP Onshore and 222,899 shares of Common Stock purchased by ACP Offshore.

F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F4 · price: Purchase prices range from $5.365 to $5.905 per share, inclusive.

F5 · balance_after: Represents 8,779,826 shares of Common Stock owned directly by ACP Onshore, 8,732,748 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor.

F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.

F9 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.

F10 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
September 10, 2019 Filed Sep 10, 2019 19:56 UTC Organogenesis Holdings Inc. ORGO · Entity 6275 PurchaseClass A common stock 12,000 $5.18 $62,206.80
Disclosure

SEC source: 0001140361-19-016483 · form4.xml · nonDerivative · entry 3

Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner

Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner

Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner

Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner

Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner

Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner

Dean Thompson · CIK 0001069096 · Director · 10% owner

Burgstahler David F · CIK 0001374179 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Notes

Disclosed balance after: 18,114,265

F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F9 · shares: Represents an aggregate of 6,016 shares of Common Stock purchased by ACP Onshore and 5,984 shares of Common Stock purchased by ACP Offshore.

F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F10 · price: Purchase prices range from $4.99 to $5.25 per share, inclusive.

F11 · balance_after: Represents 8,555,725 shares of Common Stock owned directly by ACP Onshore, 8,509,849 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor.

F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.

F12 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.

F13 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
September 09, 2019 Filed Sep 10, 2019 19:56 UTC Organogenesis Holdings Inc. ORGO · Entity 6275 PurchaseClass A common stock 25,000 $5.12 $128,022.50
Disclosure

SEC source: 0001140361-19-016483 · form4.xml · nonDerivative · entry 2

Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner

Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner

Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner

Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner

Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner

Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner

Dean Thompson · CIK 0001069096 · Director · 10% owner

Burgstahler David F · CIK 0001374179 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Notes

Disclosed balance after: 18,102,265

F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F6 · shares: Represents an aggregate of 12,534 shares of Common Stock purchased by ACP Onshore and 12,466 shares of Common Stock purchased by ACP Offshore.

F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F7 · price: Purchase prices range from $4.91 to $5.68 per share, inclusive.

F8 · balance_after: Represents 8,549,709 shares of Common Stock owned directly by ACP Onshore, 8,503,865 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor.

F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.

F12 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.

F13 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
September 06, 2019 Filed Sep 10, 2019 19:56 UTC Organogenesis Holdings Inc. ORGO · Entity 6275 PurchaseClass A common stock 500,000 $5.18 $2,592,300.00
Disclosure

SEC source: 0001140361-19-016483 · form4.xml · nonDerivative · entry 1

Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner

Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner

Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner

Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner

Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner

Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner

Dean Thompson · CIK 0001069096 · Director · 10% owner

Burgstahler David F · CIK 0001374179 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Notes

Disclosed balance after: 18,077,265

F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F3 · shares: Represents an aggregate of 250,673 shares of Common Stock purchased by ACP Onshore and 249,327 shares of Common Stock purchased by ACP Offshore.

F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F4 · price: Purchase prices range from $4.73 to $5.35 per share, inclusive.

F5 · balance_after: Represents 8,537,175 shares of Common Stock owned directly by ACP Onshore, 8,491,399 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor.

F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.

F12 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.

F13 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
September 05, 2019 Filed Sep 5, 2019 18:51 UTC Organogenesis Holdings Inc. ORGO · Entity 6275 PurchaseClass A common stock 177,600 $4.89 $868,570.56
Disclosure

SEC source: 0001140361-19-016217 · form4.xml · nonDerivative · entry 3

Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner

Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner

Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner

Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner

Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner

Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner

Dean Thompson · CIK 0001069096 · Director · 10% owner

Burgstahler David F · CIK 0001374179 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Notes

Disclosed balance after: 17,577,265

F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F9 · shares: Represents an aggregate of 89,039 shares of Common Stock purchased by ACP Onshore and 88,561 shares of Common Stock purchased by ACP Offshore.

F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F10 · price: Purchase prices range from $4.52 to $4.90 per share, inclusive.

F11 · balance_after: Represents 8,286,502 shares of Common Stock owned directly by ACP Onshore, 8,242,072 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor.

F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.

F12 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.

F13 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
September 04, 2019 Filed Sep 5, 2019 18:51 UTC Organogenesis Holdings Inc. ORGO · Entity 6275 PurchaseClass A common stock 200,000 $4.90 $979,220.00
Disclosure

SEC source: 0001140361-19-016217 · form4.xml · nonDerivative · entry 2

Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner

Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner

Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner

Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner

Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner

Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner

Dean Thompson · CIK 0001069096 · Director · 10% owner

Burgstahler David F · CIK 0001374179 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Notes

Disclosed balance after: 17,399,665

F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F6 · shares: Represents an aggregate of 100,269 shares of Common Stock purchased by ACP Onshore and 99,731 shares of Common Stock purchased by ACP Offshore.

F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F7 · price: Purchase prices range from $4.70 to $4.90 per share, inclusive.

F8 · balance_after: Represents 8,197,463 shares of Common Stock owned directly by ACP Onshore, 8,153,511 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor.

F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.

F12 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.

F13 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
September 03, 2019 Filed Sep 5, 2019 18:51 UTC Organogenesis Holdings Inc. ORGO · Entity 6275 PurchaseClass A common stock 200,000 $4.75 $949,760.00
Disclosure

SEC source: 0001140361-19-016217 · form4.xml · nonDerivative · entry 1

Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner

Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner

Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner

Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner

Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner

Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner

Dean Thompson · CIK 0001069096 · Director · 10% owner

Burgstahler David F · CIK 0001374179 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Notes

Disclosed balance after: 17,199,665

F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F3 · shares: Represents an aggregate of 100,269 shares of Common Stock purchased by ACP Onshore and 99,731 shares of Common Stock purchased by ACP Offshore.

F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.

F4 · price: Purchase prices range from $4.44 to $4.75 per share, inclusive.

F5 · balance_after: Represents 8,097,194 shares of Common Stock owned directly by ACP Onshore, 8,053,780 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor.

F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.

F12 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.

F13 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
August 19, 2019 Filed Aug 21, 2019 17:05 UTC Organogenesis Holdings Inc. ORGO · Entity 6275 Disposition to issuerWarrants (right to buy) · Derivative 4,100,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-19-015434 · form4.xml · derivative · entry 2

Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner

Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner

Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner

Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner

Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner

Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner

Dean Thompson · CIK 0001069096 · Director · 10% owner

Burgstahler David F · CIK 0001374179 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Notes

Disclosed balance after: 0

Underlying: Class A common stock · 2,050,000 shares

Expires 2023-12-10

F5 · derivative.exercise_price: Each warrant entitled the holder to purchase from the Issuer shares of Common Stock at a price of $5.75 per-half share of Common Stock (or $11.50 per whole share), subject to adjustments.

F2 · kind: Based on a ratio of 0.095 shares per warrant, ACP Onshore and ACP Offshore exchanged (with the Issuer) 2,055,510 warrants and 2,044,490 warrants, respectively, for 195,274 shares and 194,227 shares, respectively (the "Warrant Exchange").

F2 · price: Based on a ratio of 0.095 shares per warrant, ACP Onshore and ACP Offshore exchanged (with the Issuer) 2,055,510 warrants and 2,044,490 warrants, respectively, for 195,274 shares and 194,227 shares, respectively (the "Warrant Exchange").

F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thomspon Dean; and David Burgstahler.

F6 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
August 19, 2019 Filed Aug 21, 2019 17:05 UTC Organogenesis Holdings Inc. ORGO · Entity 6275 GrantClass A common stock 389,501 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-19-015434 · form4.xml · nonDerivative · entry 1

Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner

Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner

Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner

Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner

Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner

Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner

Dean Thompson · CIK 0001069096 · Director · 10% owner

Burgstahler David F · CIK 0001374179 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Notes

Disclosed balance after: 16,999,665

F2 · kind: Based on a ratio of 0.095 shares per warrant, ACP Onshore and ACP Offshore exchanged (with the Issuer) 2,055,510 warrants and 2,044,490 warrants, respectively, for 195,274 shares and 194,227 shares, respectively (the "Warrant Exchange").

F2 · price: Based on a ratio of 0.095 shares per warrant, ACP Onshore and ACP Offshore exchanged (with the Issuer) 2,055,510 warrants and 2,044,490 warrants, respectively, for 195,274 shares and 194,227 shares, respectively (the "Warrant Exchange").

F3 · balance_after: Represents 7,996,925 shares of Common Stock owned directly by ACP Onshore and 7,954,049 shares of Common Stock owned directly by ACP Offshore, in each case, following the Warrant Exchange, and 1,048,691 shares of Common Stock owned directly by the Sponsor.

F4 · balance_after: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests.Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.

F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thomspon Dean; and David Burgstahler.

F6 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
December 10, 2018 Filed Dec 13, 2018 02:41 UTC Organogenesis Holdings Inc. ORGO · Entity 6275 PurchaseClass A common stock 6,538,732 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-18-045048 · form4.xml · nonDerivative · entry 1

Avista Capital Managing Member IV, LLC · CIK 0001761175 · 10% owner

Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · 10% owner

Avista Capital Partners IV, L.P. · CIK 0001664176 · 10% owner

Avista Capital Partners IV GP, L.P. · CIK 0001761195 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Notes

Disclosed balance after: 15,561,473

F2 · kind: Represents 3,278,154 shares of Class A common stock received by Fund IV and 3,260,578 shares of Class A common stock received by Offshore Fund IV, in each case, at an exchange ratio of 2.03 shares of the Issuer's Class A common stock for each share of common stock of Organogenesis Inc. in connection with the consummation of the business combination pursuant to that certain Agreement and Plan of Merger, dated as of August 17, 2018, by and among Avista Healthcare Public Acquisition Corp., Avista Healthcare Merger Sub, Inc. and Organogenesis Inc.

F2 · shares: Represents 3,278,154 shares of Class A common stock received by Fund IV and 3,260,578 shares of Class A common stock received by Offshore Fund IV, in each case, at an exchange ratio of 2.03 shares of the Issuer's Class A common stock for each share of common stock of Organogenesis Inc. in connection with the consummation of the business combination pursuant to that certain Agreement and Plan of Merger, dated as of August 17, 2018, by and among Avista Healthcare Public Acquisition Corp., Avista Healthcare Merger Sub, Inc. and Organogenesis Inc.

F2 · price: Represents 3,278,154 shares of Class A common stock received by Fund IV and 3,260,578 shares of Class A common stock received by Offshore Fund IV, in each case, at an exchange ratio of 2.03 shares of the Issuer's Class A common stock for each share of common stock of Organogenesis Inc. in connection with the consummation of the business combination pursuant to that certain Agreement and Plan of Merger, dated as of August 17, 2018, by and among Avista Healthcare Public Acquisition Corp., Avista Healthcare Merger Sub, Inc. and Organogenesis Inc.

F3 · balance_after: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Capital Partners IV, L.P. ("Fund IV"), Avista Capital Partners (Offshore) IV, L.P. ("Offshore Fund IV"), Avista Capital Partners IV GP, L.P. ("Fund IV GP"), which is the general partner of Fund IV and Offshore Fund IV; and Avista Capital Managing Member IV, LLC, which is the general partner of Fund IV GP.

F4 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.